Stock Screener App
Frei
-
Play Store
App Store
Installieren
Installieren
Dark
DE
Sign in
Beobachtungsliste
Top-Listen
Märkte
Neu
Kryptos
Branchen
Elite
Marktsimulator
Dow:
Nasdaq:
S&P 500:
Startseite
›
NYSE: CHE
›
Finanzen
CHE
$534.72
1.33%
-7.20
Nachbörslich: 534.73
+0.01 +0.00%
Chemed Corp (CHE)
Indikator
1D
1W
1M
6M
YTD
1Y
5Y
MAX
Line
Candle
SMA
RSI
BB
Date:
2026-10-30 16:00
O:
545.01
H:
551.68
L:
533.22
C:
534.72
Vol:
180.1k
Überblick
Nachrichten
Preisverlauf
Optionskette
Finanzen
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Chemed Corp-Aktie (CHE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Periodenlänge
3 Monate
3 Monate
3 Monate
3 Monate
3 Monate
Revenues
2.39%
673.25
657.51
639.34
624.90
618.80
Cost Of Revenue
2.27%
451.78
441.75
414.17
427.99
434.11
Operating Expenses
1.94%
584.05
572.94
538.68
550.15
550.71
Selling, General, and Administrative
0.77%
115.20
114.32
105.50
105.78
100.32
Interest Income/Expense
249.41%
1.79
0.51
0.52
0.46
0.44
Costs And Expenses
1.94%
584.05
572.94
538.68
550.15
550.71
Operating Income/Loss
5.47%
89.20
84.58
100.65
74.75
68.08
Nonoperating Income/Loss
18.01%
3.91
4.77
5.31
9.25
3.47
Income/Loss From Continuing Operations Before Tax
2.80%
91.33
88.84
105.45
83.54
71.12
Income Tax Expense/Benefit, Deferred
110.03%
0.48
-4.74
10.32
-3.02
0.93
Income Tax Expense/Benefit
4.83%
23.63
22.54
28.69
19.31
18.62
Net Income/Loss
2.11%
67.70
66.30
76.75
64.24
52.49
Attributable To Parent
2.11%
67.70
66.30
76.75
64.24
52.49
Basic Average Shares
3.66%
13.17
13.68
-0.14
14.39
14.59
Diluted Average Shares
3.59%
13.20
13.69
-0.16
14.41
14.70
Basic Earnings Per Share
5.98%
5.14
4.85
5.45
4.46
3.60
Diluted Earnings Per Share
5.99%
5.13
4.84
5.45
4.46
3.57
Common Stock Dividends
0.60
0.60
0.60
0.60
0.50
Ähnlich wie CHE
PACS
$47.81
3.76%
CON
$40.38
2.11%
LFST
$13.40
1.72%
OPCH
$31.83
0.06%
UHS
$176.05
0.32%
ENSG
$181.52
2.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
In EDGAR öffnen
|
In Reuters öffnen